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Abstract
RNA-sequencing (RNA-seq) has a wide variety of
applications, but no single analysis pipeline can be
used in all cases. We review all of the major steps in
RNA-seq data analysis, including experimental design,
quality control, read alignment, quantification of gene
and transcript levels, visualization, differential gene
expression, alternative splicing, functional analysis,
gene fusion detection and eQTL mapping. We
highlight the challenges associated with each step.
We discuss the analysis of small RNAs and the
integration of RNA-seq with other functional
genomics techniques. Finally, we discuss the outlook
for novel technologies that are changing the state of
the art in transcriptomics.
Background
Transcript identification and the quantification of gene
expression have been distinct core activities in molecular
biology ever since the discovery of RNA’s role as the key
intermediate between the genome and the proteome.
The power of sequencing RNA lies in the fact that the
twin aspects of discovery and quantification can be com-
bined in a single high-throughput sequencing assay
called RNA-sequencing (RNA-seq). The pervasive adop-
tion of RNA-seq has spread well beyond the genomics
community and has become a standard part of the toolkit
used by the life sciences research community. Many varia-
tions of RNA-seq protocols and analyses have been
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published, making it challenging for new users to appreci-
ate all of the steps necessary to conduct an RNA-seq study
properly.
There is no optimal pipeline for the variety of different
applications and analysis scenarios in which RNA-seq
can be used. Scientists plan experiments and adopt dif-
ferent analysis strategies depending on the organism be-
ing studied and their research goals. For example, if a
genome sequence is available for the studied organism,
it should be possible to identify transcripts by mapping
RNA-seq reads onto the genome. By contrast, for organ-
isms without sequenced genomes, quantification would
be achieved by first assembling reads de novo into con-
tigs and then mapping these contigs onto the transcrip-
tome. For well-annotated genomes such as the human
genome, researchers may choose to base their RNA-seq
analysis on the existing annotated reference transcrip-
tome alone, or might try to identify new transcripts and
their differential regulation. Furthermore, investigators
might be interested only in messenger RNA isoform ex-
pression or microRNA (miRNA) levels or allele variant
identification. Both the experimental design and the ana-
lysis procedures will vary greatly in each of these cases.
RNA-seq can be used solo for transcriptome profiling or
in combination with other functional genomics methods
to enhance the analysis of gene expression. Finally, RNA-
seq can be coupled with different types of biochemical
assay to analyze many other aspects of RNA biology, such
as RNA–protein binding, RNA structure, or RNA–RNA
interactions. These applications are, however, beyond the
scope of this review as we focus on ‘typical’ RNA-seq.
Every RNA-seq experimental scenario could poten-
tially have different optimal methods for transcript
quantification, normalization, and ultimately differential
expression analysis. Moreover, quality control checks
should be applied pertinently at different stages of the
analysis to ensure both reproducibility and reliability of
the results. Our focus is to outline current standards
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seq data. We do not aim to provide an exhaustive com-
pilation of resources or software tools nor to indicate
one best analysis pipeline. Rather, we aim to provide a
commented guideline for RNA-seq data analysis. Figure 1
depicts a generic roadmap for experimental design and
analysis using standard Illumina sequencing. We also
briefly list several data integration paradigms that have
been proposed and comment on their potential and limi-
tations. We finally discuss the opportunities as well as
challenges provided by single-cell RNA-seq and long-
read technologies when compared to traditional short-
read RNA-seq.
Experimental design
A crucial prerequisite for a successful RNA-seq study is
that the data generated have the potential to answer the
biological questions of interest. This is achieved by first
defining a good experimental design, that is, by choosing
the library type, sequencing depth and number of repli-
cates appropriate for the biological system under study,Fig. 1 A generic roadmap for RNA-seq computational analyses. The major
and advanced analysis. The key analysis issues for each step that are listed
experimental design, sequencing design, and quality control steps. b Core
and functional profiling. c Advanced analysis includes visualization, other R
Chromatin immunoprecipitation sequencing, eQTL Expression quantitative
reads, GSEA Gene set enrichment analysis, PCA Principal component analys
Splicing quantitative trait loci, TF Transcription factor, TPM Transcripts per mand second by planning an adequate execution of the se-
quencing experiment itself, ensuring that data acquisi-
tion does not become contaminated with unnecessary
biases. In this section, we discuss both considerations.
One important aspect of the experimental design is
the RNA-extraction protocol used to remove the highly
abundant ribosomal RNA (rRNA), which typically con-
stitutes over 90 % of total RNA in the cell, leaving the
1–2 % comprising messenger RNA (mRNA) that we are
normally interested in. For eukaryotes, this involves
choosing whether to enrich for mRNA using poly(A) se-
lection or to deplete rRNA. Poly(A) selection typically
requires a relatively high proportion of mRNA with min-
imal degradation as measured by RNA integrity number
(RIN), which normally yields a higher overall fraction of
reads falling onto known exons. Many biologically rele-
vant samples (such as tissue biopsies) cannot, however,
be obtained in great enough quantity or good enough
mRNA integrity to produce good poly(A) RNA-seq li-
braries and therefore require ribosomal depletion. For
bacterial samples, in which mRNA is not polyadenylated,analysis steps are listed above the lines for pre-analysis, core analysis
below the lines are discussed in the text. a Preprocessing includes
analyses include transcriptome profiling, differential gene expression,
NA-seq technologies, and data integration. Abbreviations: ChIP-seq
loci, FPKM Fragments per kilobase of exon model per million mapped
is, RPKM Reads per kilobase of exon model per million reads, sQTL
illion
Box 1. Number of replicates
Three factors determine the number of replicates required in a
RNA-seq experiment. The first factor is the variability in the
measurements, which is influenced by the technical noise and
the biological variation. While reproducibility in RNA-seq is usually
high at the level of sequencing [1, 45], other steps such as RNA
extraction and library preparation are noisier and may introduce
biases in the data that can be minimized by adopting good
experimental procedures (Box 2). Biological variability is particular
to each experimental system and is harder to control [189].
Nevertheless, biological replication is required if inference on the
population is to be made, with three replicates being the minimum
for any inferential analysis. For a proper statistical power analysis,
estimates of the within-group variance and gene expression levels
are required. This information is typically not available beforehand
but can be obtained from similar experiments. The exact power will
depend on the method used for differential expression analysis,
and software packages exist that provide a theoretical estimate of
power over a range of variables, given the within-group variance of
the samples, which is intrinsic to the experiment [190, 191]. Table 1
shows an example of statistical power calculations over a range of
fold-changes (or effect sizes) and number of replicates in a human
blood RNA-seq sample sequenced at 30 million mapped reads. It
should be noted that these estimates apply to the average gene
expression level, but as dynamic ranges in RNA-seq data are large,
the probability that highly expressed genes will be detected as
differentially expressed is greater than that for low-count genes
[192]. For methods that return a false discovery rate (FDR), the
proportion of genes that are highly expressed out of the total set
of genes being tested will also influence the power of detection
after multiple testing correction [193]. Filtering out genes that are
expressed at low levels prior to differential expression analysis
reduces the severity of the correction and may improve the power
of detection [20]. Increasing sequencing depth also can improve
statistical power for lowly expressed genes [10, 194], and for any
given sample there exists a level of sequencing at which power
improvement is best achieved by increasing the number of
replicates [195]. Tools such as Scotty are available to calculate the
best trade-off between sequencing depth and replicate number
given some budgetary constraints [191].
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consideration is whether to generate strand-preserving li-
braries. The first generation of Illumina-based RNA-seq
used random hexamer priming to reverse-transcribe
poly(A)-selected mRNA. This methodology did not retain
information contained on the DNA strand that is actually
expressed [1] and therefore complicates the analysis and
quantification of antisense or overlapping transcripts. Sev-
eral strand-specific protocols [2], such as the widely used
dUTP method, extend the original protocol by incorporat-
ing UTP nucleotides during the second cDNA synthesis
step, prior to adapter ligation followed by digestion of the
strand containing dUTP [3]. In all cases, the size of the
final fragments (usually less than 500 bp for Illumina) will
be crucial for proper sequencing and subsequent analysis.
Furthermore, sequencing can involve single-end (SE) or
paired-end (PE) reads, although the latter is preferable for
de novo transcript discovery or isoform expression ana-
lysis [4, 5]. Similarly, longer reads improve mappability
and transcript identification [5, 6]. The best sequencing
option depends on the analysis goals. The cheaper, short
SE reads are normally sufficient for studies of gene expres-
sion levels in well-annotated organisms, whereas longer
and PE reads are preferable to characterize poorly anno-
tated transcriptomes.
Another important factor is sequencing depth or li-
brary size, which is the number of sequenced reads for a
given sample. More transcripts will be detected and their
quantification will be more precise as the sample is se-
quenced to a deeper level [1]. Nevertheless, optimal se-
quencing depth again depends on the aims of the
experiment. While some authors will argue that as few
as five million mapped reads are sufficient to quantify
accurately medium to highly expressed genes in most
eukaryotic transcriptomes, others will sequence up to
100 million reads to quantify precisely genes and tran-
scripts that have low expression levels [7]. When study-
ing single cells, which have limited sample complexity,
quantification is often carried out with just one million
reads but may be done reliably for highly expressed
genes with as few as 50,000 reads [8]; even 20,000 reads
have been used to differentiate cell types in splenic tissue
[9]. Moreover, optimal library size depends on the com-
plexity of the targeted transcriptome. Experimental results
suggest that deep sequencing improves quantification and
identification but might also result in the detection of
transcriptional noise and off-target transcripts [10]. Satur-
ation curves can be used to assess the improvement in
transcriptome coverage to be expected at a given sequen-
cing depth [10].
Finally, a crucial design factor is the number of repli-
cates. The number of replicates that should be included in
a RNA-seq experiment depends on both the amount of
technical variability in the RNA-seq procedures and thebiological variability of the system under study, as well as
on the desired statistical power (that is, the capacity for
detecting statistically significant differences in gene ex-
pression between experimental groups). These two aspects
are part of power analysis calculations (Fig. 1a; Box 1).
The adequate planning of sequencing experiments so
as to avoid technical biases is as important as good
Table 1 Statistical power to detect differential expression varies
with effect size, sequencing depth and number of replicates
Replicates per group
3 5 10
Effect size (fold change)
1.25 17 % 25 % 44 %
1.5 43 % 64 % 91 %
2 87 % 98 % 100 %
Sequencing depth (millions of reads)
3 19 % 29 % 52 %
10 33 % 51 % 80 %
15 38 % 57 % 85 %
Example of calculations for the probability of detecting differential expression
in a single test at a significance level of 5 %, for a two-group comparison using
a Negative Binomial model, as computed by the RNASeqPower package of
Hart et al. [190]. For a fixed within-group variance (package default value), the
statistical power increases with the difference between the two groups (effect
size), the sequencing depth, and the number of replicates per group. This
table shows the statistical power for a gene with 70 aligned reads, which was
the median coverage for a protein-coding gene for one whole-blood RNA-seq
sample with 30 million aligned reads from the GTEx Project [214]
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volves a large number of samples that need to be proc-
essed in several batches. In this case, including controls,
randomizing sample processing and smart management
of sequencing runs are crucial to obtain error-free data
(Fig. 1a; Box 2).
Analysis of the RNA-seq data
The actual analysis of RNA-seq data has as many varia-
tions as there are applications of the technology. In thisBox 2. Experiment execution choices
RNA-seq library preparation and sequencing procedures include
a number of steps (RNA fragmentation, cDNA synthesis, adapter
ligation, PCR amplification, bar-coding, and lane loading) that
might introduce biases into the resulting data [196]. Including
exogenous reference transcripts (‘spike-ins’) is useful both for
quality control [1, 197] and for library-size normalization [198].
For bias minimization, we recommend following the suggestions
made by Van Dijk et al. [199], such as the use of adapters with
random nucleotides at the extremities or the use of chemical-based
fragmentation instead of RNase III-based fragmentation. If the
RNA-seq experiment is large and samples have to be processed in
different batches and/or Illumina runs, caution should be taken to
randomize samples across library preparation batches and lanes so
as to avoid technical factors becoming confounded with
experimental factors. Another option, when samples are individually
barcoded and multiple Illumina lanes are needed to achieve the
desired sequencing depth, is to include all samples in each lane,
which would minimize any possible lane effect.section, we address all of the major analysis steps for a
typical RNA-seq experiment, which involve quality con-
trol, read alignment with and without a reference genome,
obtaining metrics for gene and transcript expression, and
approaches for detecting differential gene expression. We
also discuss analysis options for applications of RNA-seq
involving alternative splicing, fusion transcripts and small
RNA expression. Finally, we review useful packages for
data visualization.
Quality-control checkpoints
The acquisition of RNA-seq data consists of several
steps — obtaining raw reads, read alignment and quanti-
fication. At each of these steps, specific checks should
be applied to monitor the quality of the data (Fig. 1a).
Raw reads
Quality control for the raw reads involves the analysis of
sequence quality, GC content, the presence of adaptors,
overrepresented k-mers and duplicated reads in order to
detect sequencing errors, PCR artifacts or contamina-
tions. Acceptable duplication, k-mer or GC content
levels are experiment- and organism-specific, but these
values should be homogeneous for samples in the same
experiments. We recommend that outliers with over
30 % disagreement to be discarded. FastQC [11] is a
popular tool to perform these analyses on Illumina
reads, whereas NGSQC [12] can be applied to any plat-
form. As a general rule, read quality decreases towards
the 3’ end of reads, and if it becomes too low, bases
should be removed to improve mappability. Software
tools such as the FASTX-Toolkit [13] and Trimmomatic
[14] can be used to discard low-quality reads, trim
adaptor sequences, and eliminate poor-quality bases.
Read alignment
Reads are typically mapped to either a genome or a tran-
scriptome, as will be discussed later. An important map-
ping quality parameter is the percentage of mapped
reads, which is a global indicator of the overall sequen-
cing accuracy and of the presence of contaminating
DNA. For example, we expect between 70 and 90 % of
regular RNA-seq reads to map onto the human genome
(depending on the read mapper used) [15], with a sig-
nificant fraction of reads mapping to a limited number
of identical regions equally well (‘multi-mapping reads’).
When reads are mapped against the transcriptome, we
expect slightly lower total mapping percentages because
reads coming from unannotated transcripts will be lost,
and significantly more multi-mapping reads because of
reads falling onto exons that are shared by different
transcript isoforms of the same gene.
Other important parameters are the uniformity of read
coverage on exons and the mapped strand. If reads
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poly(A)-selected samples, this might indicate low RNA
quality in the starting material. The GC content of
mapped reads may reveal PCR biases. Tools for quality
control in mapping include Picard [16], RSeQC [17] and
Qualimap [18].
Quantification
Once actual transcript quantification values have been
calculated, they should be checked for GC content and
gene length biases so that correcting normalization
methods can be applied if necessary. If the reference
transcriptome is well annotated, researchers could
analyze the biotype composition of the sample, which is
indicative of the quality of the RNA purification step.
For example, rRNA and small RNAs should not be
present in regular polyA longRNA preparations [10, 19].
A number of R packages (such as NOISeq [19] or EDA-
Seq [20]) provide useful plots for quality control of
count data.
Reproducibility
The quality-control steps described above involve indi-
vidual samples. In addition, it is also crucial to assess the
global quality of the RNA-seq dataset by checking on
the reproducibility among replicates and for possible
batch effects. Reproducibility among technical replicates
should be generally high (Spearman R2 > 0.9) [1], but noFig. 2 Read mapping and transcript identification strategies. Three basic st
available and reads are mapped to the genome with a gapped mapper. N
without an annotation file. Novel transcripts are then functionally annotate
to the reference transcriptome using an ungapped aligner. Transcript ident
genome is available, reads need to be assembled first into contigs or trans
transcriptome and further analysis proceeds as in (b) followed by the funct
software that can be used at each analysis step are indicated in bold text. A
RSEM RNA-Seq by Expectation Maximizationclear standard exists for biological replicates, as this de-
pends on the heterogeneity of the experimental system.
If gene expression differences exist among experimental
conditions, it should be expected that biological repli-
cates of the same condition will cluster together in a
principal component analysis (PCA).
Transcript identification
When a reference genome is available, RNA-seq analysis
will normally involve the mapping of the reads onto the
reference genome or transcriptome to infer which tran-
scripts are expressed. Mapping solely to the reference
transcriptome of a known species precludes the discov-
ery of new, unannotated transcripts and focuses the ana-
lysis on quantification alone. By contrast, if the organism
does not have a sequenced genome, then the analysis
path is first to assemble reads into longer contigs and
then to treat these contigs as the expressed transcrip-
tome to which reads are mapped back again for quantifi-
cation. In either case, read coverage can be used to
quantify transcript expression level (Fig. 1b). A basic
choice is whether transcript identification and quantifi-
cation are done sequentially or simultaneously.
Alignment
Two alternatives are possible when a reference sequence
is available: mapping to the genome or mapping to the
annotated transcriptome (Fig. 2a, b; Box 3). Regardlessrategies for regular RNA-seq analysis. a An annotated genome is
ext (novel) transcript discovery and quantification can proceed with or
d. b If no novel transcript discovery is needed, reads can be mapped
ification and quantification can occur simultaneously. c When no
cripts. For quantification, reads are mapped back to the novel reference
ional annotation of the novel transcripts as in (a). Representative
bbreviations: GFF General Feature Format, GTF gene transfer format,
Box 3. Mapping to a reference
Mapping to a reference genome allows for the identification of
novel genes or transcripts, and requires the use of a gapped or
spliced mapper as reads may span splice junctions. The
challenge is to identify splice junctions correctly, especially
when sequencing errors or differences with the reference exist
or when non-canonical junctions and fusion transcripts are
sought. One of the most popular RNA-seq mappers, TopHat,
follows a two-step strategy in which unspliced reads are first
mapped to locate exons, then unmapped reads are split and
aligned independently to identify exon junctions [200, 201].
Several other mappers exist that are optimized to identify SNPs
or indels (GSNAP [202], PALMapper [203] MapSplice [204]),
detect non-canonical splice junctions (STAR [15], MapSplice
[204]), achieve ultra-fast mapping (GEM [205]) or map long-reads
(STAR [15]). Important parameters to consider during mapping
are the strandedness of the RNA-seq library, the number of
mismatches to accept, the length and type of reads (SE or PE),
and the length of sequenced fragments. In addition, existing
gene models can be leveraged by supplying an annotation file
to some read mapper in order to map exon coordinates
accurately and to help in identifying splicing events. The choice
of gene model can also have a strong impact on the quantification
and differential expression analysis [206]. We refer the reader to
[30] for a comprehensive comparison of RNA-seq mappers. If the
transcriptome annotation is comprehensive (for example, in mouse
or human), researchers may choose to map directly to a
Fasta-format file of all transcript sequences for all genes of interests.
In this case, no gapped alignment is needed and unspliced
mappers such as Bowtie [207] can be used (Fig. 2b). Mapping to
the transcriptome is generally faster but does not allow de
novo transcript discovery.
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reads may map uniquely (they can be assigned to only
one position in the reference) or could be multi-mapped
reads (multireads). Genomic multireads are primarily
due to repetitive sequences or shared domains of paralo-
gous genes. They normally account for a significant frac-
tion of the mapping output when mapped onto the
genome and should not be discarded. When the refer-
ence is the transcriptome, multi-mapping arises even
more often because a read that would have been
uniquely mapped on the genome would map equally
well to all gene isoforms in the transcriptome that share
the exon. In either case — genome or transcriptome
mapping — transcript identification and quantification
become important challenges for alternatively expressed
genes.Transcript discovery
Identifying novel transcripts using the short reads pro-
vided by Illumina technology is one of the most challen-
ging tasks in RNA-seq. Short reads rarely span across
several splice junctions and thus make it difficult to dir-
ectly infer all full-length transcripts. In addition, it is dif-
ficult to identify transcription start and end sites [21],
and tools such as GRIT [22] that incorporate other data
such as 5’ ends from CAGE or RAMPAGE typically have
a better chance of annotating the major expressed iso-
forms correctly. In any case, PE reads and higher cover-
age help to reconstruct lowly expressed transcripts, and
replicates are essential to resolve false-positive calls (that
is, mapping artifacts or contaminations) at the low end
of signal detection. Several methods, such as Cufflinks
[23], iReckon [24], SLIDE [25] and StringTie [26], in-
corporate existing annotations by adding them to the
possible list of isoforms. Montebello [27] couples iso-
form discovery and quantification using a likelihood-
based Monte Carlo algorithm to boost performance.
Gene-finding tools such as Augustus [28] can incorpor-
ate RNA-seq data to better annotate protein-coding
transcripts, but perform worse on non-coding tran-
scripts [29]. In general, accurate transcript reconstruc-
tion from short reads is difficult, and methods typically
show substantial disagreement [29].
De novo transcript reconstruction
When a reference genome is not available or is incom-
plete, RNA-seq reads can be assembled de novo (Fig. 2c)
into a transcriptome using packages such as SOAPdenovo-
Trans [30], Oases [31], Trans-ABySS [32] or Trinity [33].
In general, PE strand-specific sequencing and long reads
are preferred because they are more informative [33]. Al-
though it is impossible to assemble lowly expressed tran-
scripts that lack enough coverage for a reliable assembly,
too many reads are also problematic because they lead to
potential misassembly and increased runtimes. Therefore,
in silico reduction of the number of reads is recom-
mended for deeply sequenced samples [33]. For compara-
tive analyses across samples, it is advisable to combine all
reads from multiple samples into a single input in order
to obtain a consolidated set of contigs (transcripts),
followed by mapping back of the short reads for expres-
sion estimation [33].
Either with a reference or de novo, the complete recon-
struction of transcriptomes using short-read Illumina tech-
nology remains a challenging problem, and in many cases
de novo assembly results in tens or hundreds of contigs ac-
counting for fragmented transcripts. Emerging long-read
technologies, such as SMRT from Pacific Biosciences, pro-
vide reads that are long enough to sequence complete
transcripts for most genes and are a promising alternative
that is discussed further in the “Outlook” section below.
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The most common application of RNA-seq is to esti-
mate gene and transcript expression. This application is
primarily based on the number of reads that map to
each transcript sequence, although there are algorithms
such as Sailfish that rely on k-mer counting in reads
without the need for mapping [34]. The simplest ap-
proach to quantification is to aggregate raw counts of
mapped reads using programs such as HTSeq-count
[35] or featureCounts [36]. This gene-level (rather than
transcript-level) quantification approach utilizes a gene
transfer format (GTF) file [37] containing the genome
coordinates of exons and genes, and often discard multi-
reads. Raw read counts alone are not sufficient to com-
pare expression levels among samples, as these values
are affected by factors such as transcript length, total
number of reads, and sequencing biases. The measure
RPKM (reads per kilobase of exon model per million
reads) [1] is a within-sample normalization method that
will remove the feature-length and library-size effects.
This measure and its subsequent derivatives FPKM
(fragments per kilobase of exon model per million
mapped reads), a within-sample normalized transcript
expression measure analogous to RPKs, and TPM (tran-
scripts per million) are the most frequently reported
RNA-seq gene expression values. It should be noted that
RPKM and FPKM are equivalent for SE reads and that
FPKM can be converted into TPM using a simple
formula [38]. The dichotomy of within-sample and
between-sample comparisons has led to a lot of confu-
sion in the literature. Correcting for gene length is not
necessary when comparing changes in gene expression
within the same gene across samples, but it is necessary
for correctly ranking gene expression levels within the
sample to account for the fact that longer genes accu-
mulate more reads. Furthermore, programs such as
Cufflinks that estimate gene length from the data can
find significant differences in gene length between
samples that cannot be ignored. TPMs, which effectively
normalize for the differences in composition of the tran-
scripts in the denominator rather than simply dividing
by the number of reads in the library, are considered
more comparable between samples of different origins
and composition but can still suffer some biases. These
must be addressed with normalization techniques such
as TMM.
Several sophisticated algorithms have been developed
to estimate transcript-level expression by tackling the
problem of related transcripts’ sharing most of their
reads. Cufflinks [39] estimates transcript expression
from a mapping to the genome obtained from mappers
such as TopHat using an expectation-maximization
approach that estimates transcript abundances. This
approach takes into account biases such as the non-uniform read distribution along the gene length.
Cufflinks was designed to take advantage of PE reads,
and may use GTF information to identify expressed
transcripts, or can infer transcripts de novo from the
mapping data alone. Algorithms that quantify expression
from transcriptome mappings include RSEM (RNA-Seq
by Expectation Maximization) [40], eXpress [41], Sailfish
[35] and kallisto [42] among others. These methods allo-
cate multi-mapping reads among transcript and output
within-sample normalized values corrected for sequen-
cing biases [35, 41, 43]. Additionally, the RSEM algo-
rithm uses an expectation maximization approach that
returns TPM values [40]. NURD [44] provides an effi-
cient way of estimating transcript expression from SE
reads with a low memory and computing cost.
Differential gene expression analysis
Differential expression analysis (Fig. 1b) requires that
gene expression values should be compared among sam-
ples. RPKM, FPKM, and TPM normalize away the most
important factor for comparing samples, which is se-
quencing depth, whether directly or by accounting for
the number of transcripts, which can differ significantly
between samples. These approaches rely on normalizing
methods that are based on total or effective counts, and
tend to perform poorly when samples have heteroge-
neous transcript distributions, that is, when highly and
differentially expressed features can skew the count dis-
tribution [45, 46]. Normalization methods that take this
into account are TMM [47], DESeq [48], PoissonSeq
[49] and UpperQuartile [45], which ignore highly vari-
able and/or highly expressed features. Additional factors
that interfere with intra-sample comparisons include
changes in transcript length across samples or condi-
tions [50], positional biases in coverage along the tran-
script (which are accounted for in Cufflinks), average
fragment size [43], and the GC contents of genes (cor-
rected in the EDAseq package [21]). The NOISeq R
package [20] contains a wide variety of diagnostic plots
to identify sources of biases in RNA-seq data and to
apply appropriate normalization procedures in each case.
Finally, despite these sample-specific normalization
methods, batch effects may still be present in the data.
These effects can be minimized by appropriate experi-
mental design [51] or, alternatively, removed by batch-
correction methods such as COMBAT [52] or ARSyN
[20, 53]. These approaches, although initially devel-
oped for microarray data, have been shown to work
well with normalized RNA-seq data (STATegra project,
unpublished).
As RNA-seq quantification is based on read counts
that are absolutely or probabilistically assigned to tran-
scripts, the first approaches to compute differential ex-
pression used discrete probability distributions, such as
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binomial distribution (also known as the gamma-Poisson
distribution) is a generalization of the Poisson distribu-
tion, allowing for additional variance (called overdisper-
sion) beyond the variance expected from randomly
sampling from a pool of molecules that are characteristic
of RNA-seq data. However, the use of discrete distribu-
tions is not required for accurate analysis of differential
expression as long as the sampling variance of small read
counts is taken into account (most important for exper-
iments with small numbers of replicates). Methods for
transforming normalized counts of RNA-seq reads
while learning the variance structure of the data have
been shown to perform well in comparison to the
discrete distribution approaches described above [55,
56]. Moreover, after extensive normalization (including
TMM and batch removal), the data might have lost
their discrete nature and be more akin to a continuous
distribution.
Some methods, such as the popular edgeR [57], take
as input raw read counts and introduce possible bias
sources into the statistical model to perform an inte-
grated normalization as well as a differential expression
analysis. In other methods, the differential expression re-
quires the data to be previously normalized to remove
all possible biases. DESeq2, like edgeR, uses the negative
binomial as the reference distribution and provides its
own normalization approach [48, 58]. baySeq [59] and
EBSeq [60] are Bayesian approaches, also based on the
negative binomial model, that define a collection of
models to describe the differences among experimental
groups and to compute the posterior probability of each
one of them for each gene. Other approaches include
data transformation methods that take into account the
sampling variance of small read counts and create
discrete gene expression distributions that can be ana-
lyzed by regular linear models [55]. Finally, non-
parametric approaches such as NOISeq [10] or SAMseq
[61] make minimal assumptions about the data and esti-
mate the null distribution for inferential analysis from
the actual data alone. For small-scale studies that com-
pare two samples with no or few replicates, the estima-
tion of the negative binomial distribution can be noisy.
In such cases, simpler methods based on the Poisson
distribution, such as DEGseq [62], or on empirical distri-
butions (NOISeq [10]) can be an alternative, although it
should be strongly stressed that, in the absence of bio-
logical replication, no population inference can be made
and hence any p value calculation is invalid. Methods
that analyze RNA-seq data without replicates therefore
only have exploratory value. Considering the drop in
price of sequencing, we recommend that RNA-seq ex-
periments have a minimum of three biological replicates
when sample availability is not limiting to allow all ofthe differential expression methods to leverage reprodu-
cibility between replicates.
Recent independent comparison studies have demon-
strated that the choice of the method (or even the ver-
sion of a software package) can markedly affect the
outcome of the analysis and that no single method is
likely to perform favorably for all datasets [56, 63, 64]
(Box 4). We therefore recommend thoroughly docu-
menting the settings and version numbers of programs
used and considering the repetition of important ana-
lyses using more than one package.
Alternative splicing analysis
Transcript-level differential expression analysis can po-
tentially detect changes in the expression of transcript
isoforms from the same gene, and specific algorithms for
alternative splicing-focused analysis using RNA-seq have
been proposed. These methods fall into two major cat-
egories. The first approach integrates isoform expression
estimation with the detection of differential expression
to reveal changes in the proportion of each isoform
within the total gene expression. One such early method,
BASIS, used a hierarchical Bayesian model to directly
infer differentially expressed transcript isoforms [65].
CuffDiff2 estimates isoform expression first and then
compares their differences. By integrating the two steps,
the uncertainty in the first step is taken into consider-
ation when performing the statistical analysis to look for
differential isoform expression [66]. The flow difference
metric (FDM) uses aligned cumulative transcript graphs
from mapped exon reads and junction reads to infer iso-
forms and the Jensen-Shannon divergence to measure
the difference [67]. Recently, Shi and Jiang [68] proposed
a new method, rSeqDiff, that uses a hierarchical likeli-
hood ratio test to detect differential gene expression
without splicing change and differential isoform expres-
sion simultaneously. All these approaches are generally
hampered by the intrinsic limitations of short-read se-
quencing for accurate identification at the isoform level,
as discussed in the RNA-seq Genome Annotation As-
sessment Project paper [30].
The so-called ‘exon-based’ approach skips the estima-
tion of isoform expression and detects signals of alterna-
tive splicing by comparing the distributions of reads on
exons and junctions of the genes between the compared
samples. This approach is based on the premise that dif-
ferences in isoform expression can be tracked in the sig-
nals of exons and their junctions. DEXseq [69] and
DSGSeq [70] adopt a similar idea to detect differentially
spliced genes by testing for significant differences in read
counts on exons (and junctions) of the genes. rMATS
detects differential usage of exons by comparing exon-
inclusion levels defined with junction reads [71]. rDiff
detects differential isoform expression by comparing
Box 4. Comparison of software tools for detecting
differential gene and transcript expression
Many statistical methods are available for detecting differential gene
or transcript expression from RNA-seq data, and a major practical
challenge is how to choose the most suitable tool for a particular
data analysis job. Most comparison studies have focused on
simulated datasets [56, 208, 209] or on samples to which exogenous
RNA (‘spike-in’) has been added in known quantities [63, 196]. This
enables a direct assessment of the sensitivity and specificity of the
methods as well as their FDR control. As simulations typically rely
on specific statistical distributions or on limited experimental
datasets and as spike-in datasets represent only technical replicates
with minimal variation, comparisons using simulated datasets have
been complemented with more practical comparisons in real
datasets with true biological replicates [64, 210, 211].
As yet, no clear consensus has been reached regarding the best
practices and the field is continuing to evolve rapidly. However,
some common findings have been made in multiple comparison
studies and in different study settings. First, specific caution is
needed with all the methods when the number of replicate
samples is very small or for genes that are expressed at very low
levels [55, 64, 209]. Among the tools, limma has been shown to
perform well under many circumstances and it is also the fastest to
run [56, 63, 64]. DESeq and edgeR perform similarly in ranking genes
but are often relatively conservative or too liberal, respectively, in
controlling FDR [63, 209, 210]. SAMseq performs well in terms of
FDR but presents an acceptable sensitivity when the number of
replicates is relatively high, at least 10 [20, 55, 209]. NOISeq and
NOISeqBIO (the adaptation of NOISeq for biological replication)
are more efficient in avoiding false positive calls at the cost of
some sensitivity but perform well with different numbers of
replicates [10, 20, 212]. Cuffdiff and Cuffdiff2 have performed
surprisingly poorly in the comparisons [56, 63]. This probably
reflects the fact that detecting differential expression at the
transcript level remains challenging and involves uncertainties in
assigning the reads to alternative isoforms. In a recent comparison,
BitSeq compared favorably to other transcript-level packages such
as Cuffdiff2 [196]. Besides the actual performance, other issues
affecting the choice of the tool include ease of installation and
use, computational requirements, and quality of documentation
and instructions. Finally, an important consideration when choosing
an analysis method is the experimental design. While some of the
differential expression tools can only perform a pair-wise comparison,
others such as edgeR [57], limma-voom [55], DESeq [48], DESeq2
[58], and maSigPro [213] can perform multiple comparisons,
include different covariates or analyze time-series data.
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with or without annotated alternative isoforms [72].
DiffSplice uses alignment graphs to identify alternative
splicing modules (ASMs) and identifies differential spli-
cing using signals of the ASMs [73]. The advantage of
exon or junction methods is their greater accuracy in
identifying individual alternative splicing events. Exon-
based methods are appropriate if the focus of the study
is not on whole isoforms but on the inclusion and exclu-
sion of specific exons and the functional protein do-
mains (or regulatory features, in case of untranslated
region exons) that they contain.
Visualization
Visualization of RNA-seq data (Fig. 1c) is, in general
terms, similar to that of any other type of genomic se-
quencing data, and it can be done at the level of reads
(using ReadXplorer [74], for example) or at the level of
processed coverage (read pileup), unnormalized (for ex-
ample, total count) or normalized, using genome
browsers such as the UCSC browser [75], Integrative
Genomics Viewer (IGV) [76] (Figure S1a in Additional
file 1), Genome Maps [77], or Savant [78]. Some
visualization tools are specifically designed for visualiz-
ing multiple RNA-seq samples, such as RNAseqViewer
[79], which provides flexible ways to display the read
abundances on exons, transcripts and junctions. Introns
can be hidden to better display signals on the exons, and
the heatmaps can help the visual comparison of signals
on multiple samples (Figure S1b, c in Additional file 1).
However, RNAseqViewer is slower than IGV.
Some of the software packages for differential gene ex-
pression analysis (such as DESeq2 or DEXseq in Biocon-
ductor) have functions to enable the visualization of
results, whereas others have been developed for
visualization-exclusive purposes, such as CummeRbund
(for CuffDiff [66]) or Sashimi plots, which can be used
to visualize differentially spliced exons [80]. The advan-
tage of Sashimi plots is that their display of junction
reads is more intuitive and aesthetically pleasing when
the number of samples is small (Figure S1d in Add-
itional file 1). Sashimi, structure, and hive plots for spli-
cing quantitative trait loci (sQTL) can be obtained using
SplicePlot [81]. Splice graphs can be produced using
SpliceSeq [82], and SplicingViewer [83] plots splice junc-
tions and alternative splicing events. TraV [84] is a
visualization tool that integrates data analysis, but its
analytical methods are not applicable to large genomes.
Owing to the complexity of transcriptomes, efficient
display of multiple layers of information is still a chal-
lenge. All of the tools are evolving rapidly and we can
expect more comprehensive tools with desirable features
to be available soon. Nevertheless, the existing tools are
of great value for exploring results for individual genes
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lyses’ results can withstand detailed scrutiny or to reveal
potential complications caused by artifacts, such as 3’
biases or complicated transcript structures. Users should
visualize changes in read coverage for genes that are
deemed important or interesting on the basis of their
analysis results to evaluate the robustness of their
conclusions.
Gene fusion discovery
The discovery of fused genes that can arise from
chromosomal rearrangements is analogous to novel iso-
form discovery, with the added challenge of a much lar-
ger search space as we can no longer assume that the
transcript segments are co-linear on a single chromo-
some. Artifacts are common even using state-of-the-art
tools, which necessitates post-processing using heuristic
filters [85]. Artifacts primarily result from misalignment
of read sequences due to polymorphisms, homology, and
sequencing errors. Families of homologous genes, and
highly polymorphic genes such as the HLA genes, pro-
duce reads that cannot be easily mapped uniquely to
their location of origin in the reference genome. For
genes with very high expression, the small but non-
negligible sequencing error rate of RNA-seq will pro-
duce reads that map incorrectly to homologous loci.
Filtering highly polymorphic genes and pairs of homolo-
gous genes is recommended [86, 87]. Also recom-
mended is the filtering of highly expressed genes that
are unlikely to be involved in gene fusions, such as ribo-
somal RNA [86]. Finally, a low ratio of chimeric to wild-
type reads in the vicinity of the fusion boundary may in-
dicate spurious mis-mapping of reads from a highly
expressed gene (the transcript allele fraction described
by Yoshihara et al. [87]).
Given successful prediction of chimeric sequences, the
next step is the prioritization of gene fusions that have
biological impact over more expected forms of genomic
variation. Examples of expected variation include
immunoglobulin (IG) rearrangements in tumor samples
infiltrated by immune cells, transiently expressed trans-
posons and nuclear mitochondrial DNA, and read-
through chimeras produced by co-transcription of adja-
cent genes [88]. Care must be taken with filtering in
order not to lose events of interest. For example, remov-
ing all fusions involving an IG gene may remove real IG
fusions in lymphomas and other blood disorders; filter-
ing fusions for which both genes are from the IG locus
is preferred [88]. Transiently expressed genomic break-
point sequences that are associated with real gene fu-
sions often overlap transposons; these should be filtered
unless they are associated with additional fusion iso-
forms from the same gene pair [89]. Read-through chi-
meras are easily identified as predictions involvingalternative splicing between adjacent genes. Where
possible, fusions should be filtered by their presence in
a set of control datasets [87]. When control datasets
are not available, artifacts can be identified by their
presence in a large number of unrelated datasets, after
excluding the possibility that they represent true recur-
rent fusions [90, 91].
Strong fusion-sequence predictions are characterized
by distinct subsequences that each align with high speci-
ficity to one of the fused genes. As alignment specificity
is highly correlated with sequence length, a strong pre-
diction sequence is longer, with longer subsequences
from each gene. Longer reads and larger insert sizes pro-
duce longer predicted sequences; thus, we recommend
PE RNA-seq data with larger insert size over SE datasets
or datasets with short insert size. Another indicator of
prediction strength is splicing. For most known fusions,
the genomic breakpoint is located in an intron of each
gene [92] and the fusion boundary coincides with a
splice site within each gene. Furthermore, fusion iso-
forms generally follow the splicing patterns of wild-type
genes. Thus, high confidence predictions have fusion
boundaries coincident with exon boundaries and exons
matching wild-type exons [91]. Fusion discovery tools
often incorporate some of the aforementioned ideas to
rank fusion predictions [93, 94], though most studies
apply additional custom heuristic filters to produce a list
of high-quality fusion candidates [90, 91, 95].
Small RNAs
Next-generation sequencing represents an increasingly
popular method to address questions concerning the
biological roles of small RNAs (sRNAs). sRNAs are usu-
ally 18–34 nucleotides in length, and they include miR-
NAs, short-interfering RNAs (siRNAs), PIWI-interacting
RNAs (piRNAs), and other classes of regulatory mole-
cules. sRNA-seq libraries are rarely sequenced as deeply
as regular RNA-seq libraries because of a lack of com-
plexity, with a typical range of 2–10 million reads. Bio-
informatics analysis of sRNA-seq data differs from
standard RNA-seq protocols (Fig. 1c). Ligated adaptor
sequences are first trimmed and the resulting read-
length distribution is computed. In animals, there are
usually peaks for 22 and 23 nucleotides, whereas in
plants there are peaks for 21- and 24-nucleotide redun-
dant reads. For instance, miRTools 2.0 [96], a tool for
prediction and profiling of sRNA species, uses by default
reads that are 18–30 bases long. The threshold value de-
pends on the application, and in case of miRNAs is usu-
ally in the range of 19–25 nucleotides.
As in standard RNA-seq, sRNA reads must then be
aligned to a reference genome or transcriptome se-
quences using standard tools, such as Bowtie2 [97],
STAR [15], or Burrows-Wheeler Aligner (BWA) [98].
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and MicroRazerS [100]) that have been designed to map
short sequences with preset parameter value ranges
suited for optimal alignment of short reads. The map-
ping itself may be performed with or without mis-
matches, the latter being used more commonly. In
addition, reads that map beyond a predetermined set
number of locations may be removed as putatively ori-
ginating from repetitive elements. In the case of miR-
NAs, usually 5–20 distinct mappings per genome are
allowed. sRNA reads are then simply counted to obtain
expression values. However, users should also verify that
their sRNA reads are not significantly contaminated by
degraded mRNA, for example, by checking whether a
miRNA library shows unexpected read coverage over the
body of highly expressed genes such as GAPDH or
ACTB.
Further analysis steps include comparison with known
sRNAs and de novo identification of sRNAs. There are
class-specific tools for this purpose, such as miRDeep
[101] and miRDeep-P [102] for animal and plant miR-
NAs, respectively, or the trans-acting siRNA prediction
tool at the UEA sRNA Workbench [103]. Tools such as
miRTools 2.0 [96], ShortStack [104], and iMir [105] also
exist for comprehensive annotation of sRNA libraries
and for identification of diverse classes of sRNAs.
Functional profiling with RNA-seq
The last step in a standard transcriptomics study (Fig. 1b)
is often the characterization of the molecular functions
or pathways in which differentially expressed genes
(DEGs) are involved. The two main approaches to func-
tional characterization that were developed first for
microarray technology are (a) comparing a list of DEGs
against the rest of the genome for overrepresented func-
tions, and (b) gene set enrichment analysis (GSEA),
which is based on ranking the transcriptome according
to a measurement of differential expression. RNA-seq
biases such as gene length complicate the direct applica-
tions of these methods for count data and hence RNA-
seq-specific tools have been proposed. For example,
GOseq [106] estimates a bias effect (such as gene length)
on differential expression results and adapts the trad-
itional hypergeometric statistic used in the functional
enrichment test to account for this bias. Similarly, the
Gene Set Variation Analysis (GSVA) [107] or SeqGSEA
[108] packages also combine splicing and implement en-
richment analyses similar to GSEA.
Functional analysis requires the availability of suffi-
cient functional annotation data for the transcriptome
under study. Resources such as Gene Ontology [109],
Bioconductor [110], DAVID [111, 112] or Babelomics
[113] contain annotation data for most model species.
However, novel transcripts discovered during de novotranscriptome assembly or reconstruction would lack at
least some functional information and therefore annota-
tion is necessary for functional profiling of those results.
Protein-coding transcripts can be functionally annotated
using orthology by searching for similar sequences in
protein databases such as SwissProt [114] and in data-
bases that contain conserved protein domains such as
Pfam [115] and InterPro [116]. The use of standard vo-
cabularies such as the Gene Ontology (GO) allows for
some exchangeability of functional information across
orthologs. Popular tools such as Blast2GO [117] allow
massive annotation of complete transcriptome datasets
against a variety of databases and controlled vocabular-
ies. Typically, between 50 and 80 % of the transcripts re-
constructed from RNA-seq data can be annotated with
functional terms in this way. However, RNA-seq data
also reveal that an important fraction of the transcrip-
tome is lacking protein-coding potential. The functional
annotation of these long non-coding RNAs is more chal-
lenging as their conservation is often less pronounced
than that of protein-coding genes. The Rfam database
[118] contains most well-characterized RNA families,
such as ribosomal or transfer RNAs, while mirBase [119]
or Miranda [120] are specialized in miRNAs. These re-
sources can be used for similarity-based annotation of
short non-coding RNAs, but no standard functional an-
notation procedures are available yet for other RNA
types such as the long non-coding RNAs.
Integration with other data types
The integration of RNA-seq data with other types of
genome-wide data (Fig. 1c) allows us to connect the
regulation of gene expression with specific aspects of
molecular physiology and functional genomics. Integra-
tive analyses that incorporate RNA-seq data as the pri-
mary gene expression readout that is compared with
other genomic experiments are becoming increasingly
prevalent. Below, we discuss some of the additional chal-
lenges posed by such analyses.
DNA sequencing
The combination of RNA and DNA sequencing can be
used for several purposes, such as single nucleotide poly-
morphism (SNP) discovery, RNA-editing analyses, or ex-
pression quantitative trait loci (eQTL) mapping. In a
typical eQTL experiment, genotype and transcriptome
profiles are obtained from the same tissue type across a
relatively large number of individuals (>50) and correla-
tions between genotype and expression levels are then
detected. These associations can unravel the genetic
basis of complex traits such as height [121], disease sus-
ceptibility [122] or even features of genome architecture
[123, 124]. Large eQTL studies have shown that genetic
variation affects the expression of most genes [125–128].
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technologies for detecting eQTLs. First, it can identify
variants that affect transcript processing. Second, reads
that overlap heterozygous SNPs can be mapped to ma-
ternal and paternal chromosomes, enabling quantifica-
tion of allele-specific expression within an individual
[129]. Allele-specific signals provide additional informa-
tion about a genetic effect on transcription, and a num-
ber of computational methods have recently become
available that leverage these signals to boost power for
association mapping [130–132]. One challenge of this
approach is the computational burden, as billions of
gene–SNP associations need to be tested; bootstrapping
or permutation-based approaches [133] are frequently
used [134, 135]. Many studies have focused on testing
only SNPs in the cis region surrounding the gene in
question, and computationally efficient approaches have
been developed recently to allow extremely swift map-
ping of eQTLs genome-wide [136]. Moreover, the com-
bination of RNA-seq and re-sequencing can be used
both to remove false positives when inferring fusion
genes [88] and to analyze copy number alterations [137].
DNA methylation
Pairwise DNA-methylation and RNA-seq integration, for
the most part, has consisted of the analysis of the correl-
ation between DEGs and methylation patterns [138–
140]. General linear models [141–143], logistic regres-
sion models [143] and empirical Bayes model [144] have
been attempted among other modeling approaches. The
statistically significant correlations that were observed,
however, accounted for relatively small effects. An inter-
esting shift away from focusing on individual gene–CpG
methylation correlations is to use a network-interaction-
based approach to analyze RNA-seq in relation to DNA
methylation. This approach identifies one or more sets
of genes (also called modules) that have coordinated dif-
ferential expression and differential methylation [145].
Chromatin features
The combination of RNA-seq and transcription factor
(TF) chromatin immunoprecipitation sequencing (ChIP-
seq) data can be used to remove false positives in ChIP-
seq analysis and to suggest the activating or repressive
effect of a TF on its target genes. For example, BETA
[146] uses differential gene expression in combination
with peaks from ChIP-seq experiments to call TF tar-
gets. In addition, ChIP-seq experiments involving his-
tone modifications have been used to understand the
general role of these epigenomic changes on gene ex-
pression [147, 148]. Other RNA-ChIP-sequencing inte-
grative approaches are reviewed in [149]. Integration of
open chromatin data such as that from FAIRE-seq and
DNase-seq with RNA-seq has mostly been limited toverifying the expression status of genes that overlap
a region of interest [150]. DNase-seq can be used for
genome-wide footprinting of DNA-binding factors,
and this in combination with the actual expression
of genes can be used to infer active transcriptional
networks [150].
MicroRNAs
Integration of RNA-seq and miRNA-seq data has the
potential to unravel the regulatory effects of miRNAs on
transcript steady-state levels. This analysis is challenging,
however, because of the very noisy nature of miRNA
target predictions, which hampers analyses based on
correlations between miRNAs and their target genes.
Associations might be found in databases such as mir-
Walk [151] and miRBase [152] that offer target predic-
tion according to various algorithms. Tools such as
CORNA [153], MMIA [154, 155], MAGIA [156], and
SePIA [157] refine predictions by testing for significant
associations between genes, miRNAs, pathways and GO
terms, or by testing the relatedness or anticorrelation of
the expression profiles of both the target genes and the
associated miRNAs. In general, we recommend using
miRNA–mRNA associations that are predicted by sev-
eral algorithms. For example, in mouse, we found that
requiring miRNA–mRNA association in five databases
resulted in about 50 target mRNA predictions per
miRNA (STATegra observations).
Proteomics and metabolomics
Integration of RNA-seq with proteomics is controversial
because the two measurements show generally low cor-
relation (~0.40 [158, 159]). Nevertheless, pairwise inte-
gration of proteomics and RNA-seq can be used to
identify novel isoforms. Unreported peptides can be pre-
dicted from RNA-seq data and then used to complement
databases normally queried in mass spectrometry as
done by Low et al. [160]. Furthermore, post-translational
editing events may be identified if peptides that are
present in the mass spectrometry analysis are absent
from the expressed genes of the RNA-seq dataset. Inte-
gration of transcriptomics with metabolomics data has
been used to identify pathways that are regulated at both
the gene expression and the metabolite level, and tools
are available that visualize results within the pathway
context (MassTRIX [161], Paintomics [162], VANTED
v2 [163], and SteinerNet [164]).
Integration and visualization of multiple data types
Integration of more than two genomic data types is still
at its infancy and not yet extensively applied to functional
sequencing techniques, but there are already some tools
that combine several data types. SNMNMF [165] and
PIMiM [166] combine mRNA and miRNA expression
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mRNA interaction networks to identify miRNA–gene
regulatory modules. MONA [167] combines different
levels of functional genomics data, including mRNA,
miRNA, DNA methylation, and proteomics data to dis-
cover altered biological functions in the samples being
studied. Paintomics can integrate any type of functional
genomics data into pathway analysis, provided that the
features can be mapped onto genes or metabolites [162].
3Omics [168] integrates transcriptomics, metabolomics
and proteomics data into regulatory networks.
In all cases, integration of different datasets is rarely
straightforward because each data type is analyzed separ-
ately with its own tailored algorithms that yield results
in different formats. Tools that facilitate format conver-
sions and the extraction of relevant results can help; ex-
amples of such workflow construction software packages
include Anduril [169], Galaxy [170] and Chipster [171].
Anduril was developed for building complex pipelines
with large datasets that require automated parallelization.
The strength of Galaxy and Chipster is their usability;
visualization is a key component of their design. Simultan-
eous or integrative visualization of the data in a genome
browser is extremely useful for both data exploration and
interpretation of results. Browsers can display in tandem
mappings from most next-generation sequencing tech-
nologies, while adding custom tracks such as gene annota-
tion, nucleotide variation or ENCODE datasets. For
proteomics integration, the PG Nexus pipeline [172] con-
verts mass spectrometry data to mappings that are co-
visualized with RNA-seq alignments.
Outlook
RNA-seq has become the standard method for transcrip-
tome analysis, but the technology and tools are continu-
ing to evolve. It should be noted that the agreement
between results obtained from different tools is still un-
satisfactory and that results are affected by parameter
settings, especially for genes that are expressed at low
levels. The two major highlights in the current applica-
tion of RNA-seq are the construction of transcriptomes
from small amounts of starting materials and better
transcript identification from longer reads. The state of
the art in both of these areas is changing rapidly, but we
will briefly outline what can be done now and what can
be expected in the near future.
Single-cell RNA-seq
Single-cell RNA-seq (scRNA-seq) is one of the newest
and most active fields of RNA-seq with its unique set of
opportunities and challenges. Newer protocols such as
Smart-seq [173] and Smart-seq2 [174] have enabled us
to work from very small amounts of starting mRNA
that, with proper amplification, can be obtained fromjust a single cell. The resulting single-cell libraries enable
the identification of new, uncharacterized cell types in
tissues. They also make it possible to measure a fascinat-
ing phenomenon in molecular biology, the stochasticity
of gene expression in otherwise identical cells within a
defined population. In this context, single cell studies
are meaningful only when a set of individual cell librar-
ies are compared with the cell population, with the aim
of identifying subgroups of multiple cells with distinct
combinations of expressed genes. Differences may be due
to naturally occurring factors such as stage of the cell
cycle, or may reflect rare cell types such as cancer stem
cells. Recent rapid progress in methodologies for single-
cell preparation, including the availability of single-cell
platforms such as the Fluidigm C1 [8], has increased the
number of individual cells analyzed from a handful to 50–
90 per condition up to 800 cells at a time. Other methods,
such as DROP-seq [175], can profile more than 10,000
cells at a time. This increased number of single-cell librar-
ies in each experiment directly allows for the identification
of smaller subgroups within the population.
The small amount of starting material and the PCR
amplification limit the depth to which single-cell librar-
ies can be sequenced productively, often to less than a
million reads. Deeper sequencing for scRNA-seq will do
little to improve quantification as the number of individ-
ual mRNA molecules in a cell is small (in the order of
100–300,000 transcripts) and only a fraction of them are
successfully reverse-transcribed to cDNA [8, 176]; but
deeper sequencing is potentially useful for discovering
and measuring allele-specific expression, as additional
reads could provide useful evidence.
Single-cell transcriptomes typically include about
3000–8000 expressed genes, which is far fewer than are
counted in the transcriptomes of the corresponding
pooled populations. The challenge is to distinguish the
technical noise that results from a lack of sensitivity at
the single-molecule level [173] (where capture rates of
around 10–50 % result in the frequent loss of the most
lowly expressed transcripts) from true biological noise
where a transcript might not be transcribed and present
in the cell for a certain amount of time while the protein
is still present. The inclusion of added reference tran-
scripts and the use of unique molecule identifiers
(UMIs) have been applied to overcome amplification
bias and to improve gene quantification [177, 178].
Methods that can quantify gene-level technical variation
allow us to focus on biological variation that is likely to
be of interest [179]. Typical quality-control steps involve
setting aside libraries that contain few reads, libraries
that have a low mapping rate, and libraries that have
zero expression levels for housekeeping genes, such as
GAPDH and ACTB, that are expected to be expressed at
a detectable level.
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aims of the experiment, different bulk RNA-seq pipe-
lines and tools can be used for different stages of the
analysis as reviewed by Stegle et al. [180]. Single-cell li-
braries are typically analyzed by mapping to a reference
transcriptome (using a program such as RSEM) without
any attempt at new transcript discovery, although at
least one package maps to the genome (Monocle [181]).
While mapping onto the genome does result in a higher
overall read-mapping rate, studies that are focused on
gene expression alone with fewer reads per cell tend to
use mapping to the reference transcriptome for the sake
of simplicity. Other single-cell methods have been devel-
oped to measure single-cell DNA methylation [182] and
single-cell open chromatin using ATAC-seq [183, 184].
At present, we can measure only one functional genomic
data-type at a time in the same single cell, but we can
expect that in the near future we will be able to recover
the transcriptome of a single cell simultaneously with
additional functional data.
Long-read sequencing
The major limitation of short-read RNA-seq is the diffi-
culty in accurately reconstructing expressed full-length
transcripts from the assembly of reads. This is particu-
larly complicated in complex transcriptomes, where dif-
ferent but highly similar isoforms of the same gene are
expressed, and for genes that have many exons and pos-
sible alternative promoters or 3’ ends. Long-read tech-
nologies, such as Pacific-Biosciences (PacBio) SMRT and
Oxford Nanopore, that were initially applied to genome
sequencing are now being used for transcriptomics and
have the potential to overcome this assembly problem.
Long-read sequencing provides amplification-free, single-
molecule sequencing of cDNAs that enables recovery of
full-length transcripts without the need for an assembly
step. PacBio adds adapters to the cDNA molecule and cre-
ates a circularized structure that can be sequenced with
multiple passes within one single long read. The Nano-
pore GridION system can directly sequence RNA strands
by using RNA processive enzymes and RNA-specific
bases. Another interesting technology was previously
known as Moleculo (now Illumina’s TruSeq synthetic
long-read technology), where Illumina library preparation
is multiplexed and restricted to a limited number of long
DNA molecules that are separately bar-coded and pooled
back for sequencing. As one barcode corresponds to a
limited number of molecules, assembly is greatly simpli-
fied and unambiguous reconstruction to long contigs is
possible. This approach has recently been published for
RNA-seq analysis [185].
PacBio RNA-seq is the long-read approach with the
most publications to date. The technology has proven
useful for unraveling isoform diversity at complex loci[186], and for determining allele-specific expression
from single reads [187]. Nevertheless, long-read sequen-
cing has its own set of limitations, such as a still high
error rate that limits de novo transcript identifications
and forces the technology to leverage the reference gen-
ome [188]. Moreover, the relatively low throughput of
SMRT cells hampers the quantification of transcript ex-
pression. These two limitations can be addressed by
matching PacBio experiments with regular, short-read
RNA-seq. The accurate and abundant Illumina reads
can be used both to correct long-read sequencing errors
and to quantify transcript levels [189]. Updates in PacBio
chemistry are increasing sequencing lengths to produce
reads with a sufficient number of passes over the
cDNA molecule to autocorrect sequencing errors. This
will eventually improve sequencing accuracy and allow
for genome-free determination of isoform-resolved
transcriptomes.
Additional file
Additional file 1: Figure S1. Screenshots of RNA-seq data visualization.
a Integrative Genomics Viewer (IGV) [77] display of a gene detected as
differentially expressed between the two groups of samples by DEGseq
[62]. The bottom track in the right panel is the gene annotation. The
tracks are five samples from each group. b RNAseqViewer [80] display of
the same data as in (a). c RNAseqViewer heatmap display of a gene
detected as differentially spliced between two groups by both DSGSeq
[70] and DEXSeq [69]. Introns are hidden in the display to emphasize the
signals on the exons. d MISO [81] display of another gene detected as
differentially spliced, with junction reads illustrated. (PDF 1152 kb)
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